New Clues To Understanding Huntington Disease: Inclusion Bodies May Protect Neurons By Linda Carroll Neurology Today, December, 2004 Using a robotic microscope to approximate time-lapse photography, researchers have found evidence that inclusion bodies, one of the hallmarks of Huntington’s disease, may actually protect neurons rather than damage them. In the new study, published in Nature, investigators found that... MORE |
Follow That Cell Today's Science on File, December, 2004 Clumps of mutant protein may not sound very appealing. But a new study by neurologist Steve Finkbeiner has shown that mutant protein clumps are actually a good thing––at least for people suffering from Huntington's disease. Moreover, the innovative equipment... MORE [PDF] |
Research group plans expansion in new S.F. digs By Daniel S. Levine San Francisco Business Times, December 10, 2004 The J. David Gladstone Institutes will boost its research staff now that its gleaming new laboratories at Mission Bay are providing long-needed room to grow. The group of medical research institutes affiliated with UCSF plans to increase its ranks to 520 during the next five years... MORE |
Gladstone Institutes Recognize Willie Brown UCSF Today, December 9, 2004 At the December 6 dedication ceremony, Warner Greene, director of the Gladstone Institute of Virology and Immunology (GIVI), praised former San Francisco Mayor Willie Brown for “his strong hand in shaping the Gladstone Institutes”... MORE |
Gladstone Scientist Offers Insight on Stem Cell Research UCSF Today, December 9, 2004 Researchers and staff at the Gladstone Institutes welcomed the community to tour their new six-story building at Mission Bay on Monday, showcasing leading-edge scientific knowledge in coronary disease, HIV/AIDS and neurodegenerative diseases. Bruce Conklin, an investigator in the Gladstone Institute of Cardiovascular Disease... MORE |
Gladstone Institutes Dedicate Mission Bay Research Building UCSF Today, December 7, 2004 The J. David Gladstone Institutes, celebrating its 25th anniversary of scientific collaboration and achievement, dedicated its new six-story biomedical research building in Mission Bay on Monday. “This building marks a true milestone in Gladstone's history...” MORE |
A KCBS-AM News Report about the dedication of the new Gladstone building at Mission Bay Includes quote from Gladstone President Dr. Robert Mahley and former San Francisco Mayor Willie BrownDecember 6, 2004 Download Audio Clip(1.2mb)
|
Biomed Doctors Move: New Mission Bay Site to House Research Facility
By Bonnie Eslinger
The San Francisco Examiner, December 6, 2004
Today, the University of California, San Francisco is celebrating its affiliation with a new biomedical research facility devoted to curing three of the world's most devastating diseases: heart disease, AIDS and Alzheimer's. Located in Mission Bay, the new six-story, 190,000-square-foot J. David Gladstone Institutes... MORE
|
Inclusion bodies acquitted: In Huntington's disease, clumps of mutant protein seem to be protective rather than harmful  By Maria W. Anderson The Scientist, October 14, 2004 Inclusion bodies play a protective, not pathogenic, role in Huntington disease, according to this week's Nature cover story by Steven Finkbeiner, from the Gladstone Institute of Neurological Disease... MORE |
Radical rethink of Huntington's disease By Philip Cohen New Scientist, October 13, 2004 Clumps of defective proteins, long implicated in killing off part of the brain in Huntington's disease, may actually be helping these neurons to survive. The discovery could redirect efforts to develop treatments... MORE |
A KPIX-TV(CBS) News Report on Gladstone's move to Mission Bay includes a look inside the new building and quotes from Lennart Mucke and Warner GreeneOctober 10, 2004 Download Video Clip(2.7mb) Requires Quicktime Player |
$2.5 Million AIDS Grant Awarded Veteran Researcher to Study How Body Can Suppress HIV By Sabin Russell San Francisco Chronicle, September 30, 2004 San Francisco AIDS researcher Dr. Joseph 'Mike' McCune was named Wednesday as one of nine winners of $2.5 million grants from the National Institutes of Health to carry out innovative medical research... MORE |
Boost for Biotech in S.F. : Gladstone Institutes to Open Mission Bay Research Center By Dan Levy San Francisco Chronicle, September 10, 2004 There are no biotech companies at Mission Bay or anywhere else in San Francisco. The opening next month of the $72 million J. David Gladstone Institutes building, a center for biomedical research, might begin to change that... MORE |
Second Chances: A Batch of New Drugs Could Be the Salvation for Failing Regimens By Bob Adams HIV Plus, August, 2004 For HIV-positive people who have developed resistance to available antiretroviral medications, the pipeline of new anti-HIV drugs is something of a mixed blessing... MORE |
Tweaking the Genes: Sweating the Small Stuff in Order to Stop HIV By Bob Adams HIV Plus, August, 2004 One of the most compelling areas of HIV treatment research combines thenewest, cutting-edge science with ancient immune system defenses that aremillions of years old. Called RNA interference... MORE |
Robert Mahley TV Interview, June, 2004 Comcast Cable interview with Gladstone President Robert Mahley on cardiovascular issues, aired on CNN Local Edition throughout June, 2004...View
Quicktime Movie |
$72M Biomed Facility Opening at Mission Bay By Radhika Kaushik Silicon Valley Biz Ink, June 18, 2004 Come October, San Francisco's Mission Bay will get a spanking new $72 million private biomedical research facility--the newest landmark in the city's evolving biotech corridor... MORE |
Statin quo? The pros and cons of direct-to-consumer use By Susan J. Landers American Medical News, June 7, 2004 Millions of people worldwide use statins, and the medication's safety record is admirable, so why not allow sales of these lifesavers without a prescription?... MORE |
 KGO-TV (ABC) News Report on AIDS Education Includes Quote from Dr. Warner C. Greene April 19, 2004 |  |
|
Deals of the Year: Best New Office/R&D Development Finalist San Francisco Business Times, March 24, 2004
 – Download a pdf – [2mb] |
Immunologist Focuses on HIV San Jose Mercury News, January 7, 2003
As the director
of the Gladstone Institute of Virology and Immunology in San Francisco,
Dr. Warner Greene works with his team of researchers to understand the most
serious epidemic in the world, HIV... MORE
|
NIH Awards $8M To UCSF, Gladstone Institute San Francisco Business Times, August 13, 2002 The National Institutes for Health has awarded the UCSF-Gladstone Institute of Virology and Immunology Center for AIDS Research (CFAR) $8 million for five years... MORE |
Growth In HIV Resistant To Drugs San Jose Mercury News, August 8, 2002 More than one-fifth of people recently infected in the United States and Canada with the virus that causes AIDS have strains that do not respond to some of the best anti-viral medications, according to a study in today’s New England Journal of
Medicine... MORE
|
Promising AIDS Drugs Raising Hopes By Sabin Russell San Francisco Chronicle, July 9, 2002 For the first time in years, American drug researchers have begun testing a new class of AIDS drugs on humans, the researchers said Monday at the 14th International AIDS Conference... MORE |
Drug-Resistant HIV on Increase By Randy Dotinga HealthScout, July 8, 2002 In another sign that AIDS is evolving into a different kind of threat, researchers have found a growing number of newly infected people are immune to the two most powerful kinds of HIV drugs... MORE
|
Innovations
Edited by Neil Gross
Business Week, June 24, 2002
Using conventional microscopes, Steven Finkbeiner was unable to fully monitor neurons ravaged by Huntington's disease. So the researcher at the Gladstone Institute of Neurological Disease invented a better scope... MORE
|